Search

everythinglearnresearchcommunity

for

Search:↓

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Topical Vorinostat shows promise for treating alopecia areata by promoting hair regrowth.

An HIV patient's complete hair loss was reversed after switching from lopinavir/ritonavir to nelfinavir.

Some minoxidil combinations can help differentiate leukemia cells without harming other cells.

Ultraviolet light treatment with trioxsalen was ineffective for vitiligo in the cases described.

Imuvert can prevent some chemotherapy-induced hair loss.

Kantavallabha rasa may help manage PCOS symptoms effectively.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Minoxidil can cause severe body swelling and fluid buildup, which improves after stopping the drug and using diuretics.

Vinblastine and its metabolites may cause nausea and hair loss by binding to specific receptors and could lead to better chemotherapy drugs with fewer side effects.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

This document studied minoxidil in healthy volunteers. Minoxidil is quickly absorbed and eliminated from the body.

A woman with Lupus Vasculitis improved after treatment with steroids and other medications.

Lithium can cause skin discoloration even at normal levels, so monitor for signs of intoxication.

Chemotherapy with docetaxel and cisplatin can cause severe low potassium, requiring careful monitoring and treatment.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Some antiseizure medications can cause reversible hair loss, with valproate, lamotrigine, and carbamazepine being the most common.

Certain medications can cause gum problems, so patients and healthcare providers should be aware and monitor oral health.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

Tolvaptan can slow kidney disease progression, but doesn't affect mortality or kidney failure.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

Sodium valproate can rarely cause curly hair in children.

New lipid/fiber microplexes improve mRNA therapy for degenerative diseases by enhancing cell function and treatment effectiveness.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.